Alps Advisors Inc

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-30
Total Holdings
1,028
Total Value
17244920728
Accession Number
0001398344-25-008194
Form Type
13F-HR
Manager Name
Alps Advisors Inc
Data Enrichment
97% identified
996 identified32 unidentified

Holdings

1,028 positions
Manager:
Search and click to pin securities to the top
Page 49 of 50
Ready Capital Corp
Shares:
38398(-3.5%)
Value:
$195.4M(-28.0%)
Vanda Pharmaceuticals Inc.
Shares:
41993(-10.9%)
Value:
$192.7M(-14.7%)
MBX Biosciences, Inc.
Shares:
26034(-3.6%)
Value:
$192.1M(-61.4%)
Olema Pharmaceuticals, Inc.
Shares:
50484(+8.9%)
Value:
$189.8M(-29.7%)
COMPASS Pathways plc
Shares:
66231(+19.7%)
Value:
$189.4M(-9.4%)
ACELYRIN, Inc.
Shares:
74640(-8.0%)
Value:
$184.4M(-27.6%)
IRONWOOD PHARMACEUTICALS INC
Shares:
116860(-9.7%)
Value:
$171.8M(-70.0%)
iTeos Therapeutics, Inc.
Shares:
28646(-3.0%)
Value:
$171.0M(-24.6%)
AVINO SILVER & GOLD MINES LTD
Shares:
92088(+70.3%)
Value:
$169.4M(+255.6%)
Annexon, Inc.
Shares:
82626(-4.1%)
Value:
$159.5M(-63.9%)
Eledon Pharmaceuticals, Inc.
Shares:
44436(-8.0%)
Value:
$150.6M(-24.3%)
Y-mAbs Therapeutics, Inc.
Shares:
33309(-8.0%)
Value:
$147.6M(-48.0%)
SITE Centers Corp.
Shares:
10629(-3.5%)
Value:
$136.5M(-19.0%)
CARGO Therapeutics, Inc.
Shares:
33158(-10.9%)
Value:
$135.0M(-74.8%)
Rezolute, Inc.
Shares:
43086(-8.0%)
Value:
$124.9M(-45.6%)
Aclaris Therapeutics, Inc.
Shares:
78782(+36.4%)
Value:
$120.5M(-15.8%)
Neumora Therapeutics, Inc.
Shares:
114371(-12.4%)
Value:
$114.4M(-91.7%)
4D Molecular Therapeutics, Inc.
Shares:
32811(-12.2%)
Value:
$106.0M(-49.1%)
Larimar Therapeutics, Inc.
Shares:
47460(-8.0%)
Value:
$102.0M(-48.9%)
Alector, Inc.
Shares:
74933(-5.3%)
Value:
$92.2M(-38.4%)